| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 10/07/2004 | WO2004085382A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same |
| 10/07/2004 | WO2004084901A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk |
| 10/07/2004 | WO2004084891A1 Methods for treating inflammatory conditions or inhibiting jnk |
| 10/07/2004 | WO2004084813A2 Chemical compounds |
| 10/07/2004 | WO2004084634A1 N-phenyl- ‘ (4-pyridyl)- azinyl!amine derivatives as plant protection agents |
| 10/07/2004 | WO2004074276B1 BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| 10/07/2004 | WO2003068757A9 Novel pyridin- and pyrimidin-derivatives |
| 10/07/2004 | US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis |
| 10/07/2004 | US20040198980 Selective rxr ligands |
| 10/07/2004 | US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders |
| 10/07/2004 | US20040198796 Compounds and methods for treating urinary incontinence |
| 10/07/2004 | US20040198790 Triazole compound containing a phosphonate group |
| 10/07/2004 | US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 10/07/2004 | US20040198758 N-heterocyclyl substituted thienyloxy-pyrimidines used as herbicides |
| 10/07/2004 | US20040198742 Substituted 3-(benzoylureido) thiophene derivatives, processes for preparing them and their use |
| 10/07/2004 | US20040198740 Therapies relating to combinations of aldose reductase inhibitors and cyclooxygenase-2 |
| 10/07/2004 | US20040198739 Prevention reproduction of virus |
| 10/07/2004 | US20040198736 Non-nucleoside reverse transcriptase inhibitors |
| 10/07/2004 | US20040198733 Obesity; antidiabetic agents; cardiovascular disorders; antilipemic agentsl circadian rhythm disorders; hypotensive agents; antidepressants; anxiolytic agents |
| 10/07/2004 | US20040198732 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals |
| 10/07/2004 | US20040198731 Antidiabetic agents; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents; circidian rhythm disorders |
| 10/07/2004 | US20040198701 EP4 receptor agonist, compositions and methods thereof |
| 10/07/2004 | US20040198609 Herbicides for plants and crops; agriculture |
| 10/07/2004 | DE10313683A1 Substituierte Pyri(mi)din(thio)carboxamide Substituted pyri (mi) dine (thio) carboxamides |
| 10/07/2004 | CA2520443A1 Methods for treating inflammatory conditions or inhibiting jnk |
| 10/07/2004 | CA2520440A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk |
| 10/07/2004 | CA2520405A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 10/07/2004 | CA2519901A1 Bioreductively-activated prodrugs |
| 10/07/2004 | CA2519288A1 N-phenyl-[(4-pyridyl)- azinyl]amine derivatives as plant protection agents |
| 10/07/2004 | CA2518823A1 Benzyl-pyridazinons as reverse transcriptase inhibitors |
| 10/06/2004 | EP1464335A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist |
| 10/06/2004 | EP1463726A2 Aromatic thioether liver x-receptor modulators |
| 10/06/2004 | EP1463724A1 Pyrrolidone carboxamides |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463505A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 10/06/2004 | EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 10/06/2004 | EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors |
| 10/06/2004 | EP1027336B1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 10/06/2004 | EP0915867B1 Thienylcyclohexane derivatives for thienylcyclohexyl synthesis |
| 10/06/2004 | CN1169798C Novel diazo alcoholic antifungal compound and its preparing process |
| 10/06/2004 | CN1169795C Cycloamine substituted nitrogenous heterocyclic compounds and its composition |
| 10/06/2004 | CN1169792C Substituted vinylpyridine derivatives and drugs containing the same |
| 10/06/2004 | CN1169789C Aminoalkoxy carbazoles for treatment of CNS diseases |
| 10/05/2004 | US6800760 Inhibitors of vascular endothelial growth factor receptor tyrosine kinase |
| 10/05/2004 | US6800656 Tricyclic compounds and method of treating herpes virus |
| 10/05/2004 | US6800651 Potentiators of glutamate receptors |
| 10/05/2004 | US6800646 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 10/05/2004 | US6800645 Substituted azabicyclic compounds |
| 10/05/2004 | US6800644 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 10/05/2004 | US6800590 2-Pyrimidinyloxy-n-aryl-benzylamine derivatives,their processes and uses |
| 10/05/2004 | CA2282834C Novel hexanoic acid derivatives |
| 09/30/2004 | WO2004083204A1 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists |
| 09/30/2004 | WO2004083174A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors |
| 09/30/2004 | WO2004082687A1 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors |
| 09/30/2004 | WO2004082677A1 Substituted p-diaminobenzene derivatives |
| 09/30/2004 | WO2004082623A2 Substituted piperidine compounds |
| 09/30/2004 | WO2004058143A3 High specificity anticancer pharmacological drug system, drug synthesis, and drug development process |
| 09/30/2004 | WO2004050084A3 Ace-inhibitors having antioxidant and nitricoxid-donor activity |
| 09/30/2004 | WO2004041209A3 Transcription factor modulating compounds and methods of use thereof |
| 09/30/2004 | WO2003088903A3 Compounds, compositions, and methods |
| 09/30/2004 | WO2003014075A3 Novel gamma secretase inhibitors |
| 09/30/2004 | US20040192944 14-Hydrido-9beta-hydroxytetracyclic taxanes |
| 09/30/2004 | US20040192942 Fluorinated pi-bridge second order nonlinear optical chromophores and electro-optic devices therefrom |
| 09/30/2004 | US20040192940 Nonlinear response; electrical communication; mixture of thiophene compound in polymer matrix |
| 09/30/2004 | US20040192930 such as 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide for treatment of arthritis |
| 09/30/2004 | US20040192927 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof |
| 09/30/2004 | US20040192767 EP4 receptor antagonists |
| 09/30/2004 | US20040192757 Reacting a 2-pyrrolidinone with alpha-keto acid; cyclization, ammonolysis , catalytic hydrogenation |
| 09/30/2004 | US20040192752 Anti-HIV pyrazole derivatives |
| 09/30/2004 | US20040192749 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 09/30/2004 | US20040192748 Heterocyclic compounds |
| 09/30/2004 | US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide |
| 09/30/2004 | US20040192728 Antiinflammatory agents; analgesics |
| 09/30/2004 | US20040192720 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 09/30/2004 | US20040192712 Insecticides; for human or veterinary medicine |
| 09/30/2004 | US20040192710 Such as trans-4-amino-3,4-dihydro-2,2-dimethyl-6-cyano-2H-benzopyran; for use as antiarrhythmic agents |
| 09/30/2004 | US20040192707 Compounds and methods for the treatment or prevention of Flavivirus infections |
| 09/30/2004 | US20040192701 Phenlypyridine carbonyl piperazine derivative |
| 09/30/2004 | US20040192693 Antidiabetic agents; arteriosclerosis; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents |
| 09/30/2004 | US20040192687 Dna-pk inhibitors |
| 09/30/2004 | US20040192685 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 09/30/2004 | US20040192667 Novel pyrazole analogs acting on cannabinoid receptors |
| 09/30/2004 | US20040192666 Nonnucleoside reverse transcriptase inhibitors |
| 09/30/2004 | US20040192578 High specificity anticancer drug design process |
| 09/30/2004 | US20040191210 Compounds |
| 09/30/2004 | CA2519582A1 Substituted p-diaminobenzene derivatives |
| 09/30/2004 | CA2517446A1 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists |
| 09/29/2004 | EP1461333A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461332A2 Production of chirally pure alpha-amino acids and n-sulfonyl alpha-amino acids |
| 09/29/2004 | EP1461327A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461321A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 09/29/2004 | EP1461313A1 Human adam-10 inhibitors |
| 09/29/2004 | EP1389202B1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 09/29/2004 | EP1192189B1 Catalysts containing n-pyrrolyl substituted nitrogen donors |
| 09/29/2004 | EP1189905B1 Substituted heterocycle fused gamma-carbolines |
| 09/29/2004 | EP1189881B1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/29/2004 | EP1181278B1 Cyclic amine derivatives and their uses |
| 09/29/2004 | EP1165557B1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS |
| 09/29/2004 | EP1114033B1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 09/29/2004 | EP1051397A4 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound |